MILLENNIAL POTASH CORP (MLP.CA) Stock Fundamental Analysis

TSX-V:MLP • CA60041F1018

2.58 CAD
-0.02 (-0.77%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, MLP scores 2 out of 10 in our fundamental rating. MLP was compared to 29 industry peers in the Chemicals industry. The financial health of MLP is average, but there are quite some concerns on its profitability. MLP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MLP has reported negative net income.
  • MLP had a negative operating cash flow in the past year.
  • MLP had negative earnings in each of the past 5 years.
  • In the past 5 years MLP always reported negative operating cash flow.
MLP.CA Yearly Net Income VS EBIT VS OCF VS FCFMLP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • MLP's Return On Assets of -26.44% is on the low side compared to the rest of the industry. MLP is outperformed by 65.52% of its industry peers.
  • MLP has a Return On Equity (-29.50%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -26.44%
ROE -29.5%
ROIC N/A
ROA(3y)-37.15%
ROA(5y)-36.6%
ROE(3y)-42.13%
ROE(5y)-39.99%
ROIC(3y)N/A
ROIC(5y)N/A
MLP.CA Yearly ROA, ROE, ROICMLP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • MLP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLP.CA Yearly Profit, Operating, Gross MarginsMLP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

6

2. Health

2.1 Basic Checks

  • MLP has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MLP has more shares outstanding
  • The debt/assets ratio for MLP has been reduced compared to a year ago.
MLP.CA Yearly Shares OutstandingMLP.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MLP.CA Yearly Total Debt VS Total AssetsMLP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 51.15 indicates that MLP is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 51.15, MLP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • MLP has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MLP (0.00) is better than 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 51.15
ROIC/WACCN/A
WACCN/A
MLP.CA Yearly LT Debt VS Equity VS FCFMLP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 25.47 indicates that MLP has no problem at all paying its short term obligations.
  • MLP has a Current ratio of 25.47. This is amongst the best in the industry. MLP outperforms 100.00% of its industry peers.
  • MLP has a Quick Ratio of 25.47. This indicates that MLP is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 25.47, MLP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 25.47
Quick Ratio 25.47
MLP.CA Yearly Current Assets VS Current LiabilitesMLP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 5M 10M 15M

0

3. Growth

3.1 Past

  • The earnings per share for MLP have decreased strongly by -60.78% in the last year.
EPS 1Y (TTM)-60.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-170.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • MLP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.36% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.82%
EPS Next 2Y24.66%
EPS Next 3Y-36.2%
EPS Next 5Y-18.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MLP.CA Yearly EPS VS EstimatesMLP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 2030 2031 2032 0 0.5 1

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MLP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MLP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLP.CA Price Earnings VS Forward Price EarningsMLP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLP.CA Per share dataMLP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

  • A cheap valuation may be justified as MLP's earnings are expected to decrease with -36.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.66%
EPS Next 3Y-36.2%

0

5. Dividend

5.1 Amount

  • No dividends for MLP!.
Industry RankSector Rank
Dividend Yield 0%

MILLENNIAL POTASH CORP

TSX-V:MLP (2/27/2026, 7:00:00 PM)

2.58

-0.02 (-0.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.18%
Inst Owner ChangeN/A
Ins Owners38.98%
Ins Owner ChangeN/A
Market Cap304.93M
Revenue(TTM)N/A
Net Income(TTM)-8.98M
Analysts84
Price Target4.93 (91.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.69%
PT rev (3m)85.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.02
P/tB 10.02
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.44%
ROE -29.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-37.15%
ROA(5y)-36.6%
ROE(3y)-42.13%
ROE(5y)-39.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4818.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 25.47
Quick Ratio 25.47
Altman-Z 51.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1622.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-170.8%
EPS Next Y10.82%
EPS Next 2Y24.66%
EPS Next 3Y-36.2%
EPS Next 5Y-18.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-151.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.69%
EBIT Next 3Y-0.09%
EBIT Next 5Y14.87%
FCF growth 1Y-127.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.88%
OCF growth 3YN/A
OCF growth 5YN/A

MILLENNIAL POTASH CORP / MLP.CA FAQ

What is the fundamental rating for MLP stock?

ChartMill assigns a fundamental rating of 2 / 10 to MLP.CA.


Can you provide the valuation status for MILLENNIAL POTASH CORP?

ChartMill assigns a valuation rating of 0 / 10 to MILLENNIAL POTASH CORP (MLP.CA). This can be considered as Overvalued.


What is the profitability of MLP stock?

MILLENNIAL POTASH CORP (MLP.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for MLP stock?

The financial health rating of MILLENNIAL POTASH CORP (MLP.CA) is 6 / 10.


What is the earnings growth outlook for MILLENNIAL POTASH CORP?

The Earnings per Share (EPS) of MILLENNIAL POTASH CORP (MLP.CA) is expected to grow by 10.82% in the next year.